1. Celgene wins FDA approval for drug key to Bristol buyout — FDA approves TAVR valves for low-risk patients — Warning signs always there for the Novartis-AveXis deal — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

End of year Layoffs

Discussion in 'Allergan' started by anonymous, Jun 28, 2019 at 6:04 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


    Lump sum
     
  2. anonymous

    anonymous Guest

    One never knows...
     
  3. anonymous

    anonymous Guest

    “Don’t be foolish.” Fuck you. Like you know a fucking thing. Eat a pile of shit dude.
     
  4. anonymous

    anonymous Guest

    Tension anyone??? Unfortunately I do know- just a roll of the dice. Don’t say I didn’t warn you . . .
     
  5. anonymous

    anonymous Guest

    Ya don’t know shit, dude. Ya don’t know shit. There is not a rep, dm, vp anyone else that has any real knowledge of what is going to happen. The people making the decisions aren’t asking or telling anyone outside of the room what’s going or what going to happen until the day the calls are made.
     
  6. anonymous

    anonymous Guest

    Outside observer here but Allergan reps are gonna be part of a bloodbath. Y’all dont have your head in the sand. Start looking for jobs now. They’re very very difficult to find and then get hired for
     
  7. anonymous

    anonymous Guest

    Saying that the guy doesn’t know who or when, not saying that it isn’t going to happen. Everyone at Allergan knows that this is over and the majority are looking.
     
  8. anonymous

    anonymous Guest

    Any other departments affected? For e.g. regulatory affairs
     
  9. anonymous

    anonymous Guest

    i can’t stop laughing after talking to a legacy AGN rep- she thinks she gonna be alright, haha. Although her numbers look good right now- ooops. She’s prime for eliminating. See ya... this fall before acquisition- they don’t wanna pay ya and no trip sista.
     
  10. anonymous

    anonymous Guest

    idiots
     
  11. anonymous

    anonymous Guest

    Deal is dying arbitrage spread , debt, is going to kill the buyout look it up ...heard it here first
     
  12. anonymous

    anonymous Guest

    Thoughts on Eye Care division?
     
  13. anonymous

    anonymous Guest

    Unfortunately Eye Care is the definition of low growth/no growth with nothing exciting or meaningful to look forward to. Record of launch failures and nothing exciting on horizon doesn’t bode well for the group
     
  14. anonymous

    anonymous Guest

    What you see and what you hear depends a great deal on where you are standing. Eye Care has a promising future!
     
  15. anonymous

    anonymous Guest

    Ha! Which division???